Issued Patents All Time
Showing 1–25 of 25 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9618515 | Assay to capture and detect circulating multiple myeloma cells from blood | Mark Carle Connelly, Galla Chandra Rao, Marielena Mata, Carrie Morano | 2017-04-11 |
| 8329422 | Analysis of circulating tumor cells, fragments, and debris | Galla Chandra Rao, Christopher Larson, Madeline Repollet, Herman Rutner, Leon W. M. M. Terstappen +1 more | 2012-12-11 |
| 7863012 | Analysis of circulating tumor cells, fragments, and debris | Galla Chandra Rao, Christopher Larson, Madeline Repollet, Herman Rutner, Leon W. M. M. Terstappen +1 more | 2011-01-04 |
| 6967219 | Reversing or preventing premature vascular senescence | Michael Goligorsky | 2005-11-22 |
| 6784178 | Pharmacotherapy for vascular dysfunction associated with deficient nitric oxide bioactivity | Caroline Jones | 2004-08-31 |
| 6274581 | Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis | — | 2001-08-14 |
| 6231894 | Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase | Jonathan S. Stamler, Brian J. Day, Owen W. Griffith | 2001-05-15 |
| 6153615 | Blocking induction of tetrahydrobioterin to block induction of nitric oxide synthesis | — | 2000-11-28 |
| 5880124 | Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis | — | 1999-03-09 |
| 5877176 | Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis | — | 1999-03-02 |
| 5874433 | Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis | — | 1999-02-23 |
| 5776979 | Method of use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension | Robert G. Kilbourn, Owen W. Griffith | 1998-07-07 |
| 5770623 | Argine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor | Robert G. Kilbourn, Roberto Levi, Owen W. Griffith | 1998-06-23 |
| 5723448 | Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction | Owen W. Griffith | 1998-03-03 |
| 5646001 | Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof | Leon W. M. M. Terstappen, Galla Candra Rao, Dhanesh Gohel, Brian P. Feeley, Ellen S. Church +1 more | 1997-07-08 |
| 5545625 | Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction | Owen W. Griffith | 1996-08-13 |
| 5534545 | Parenteral amino acid formulations for the inhibition of systemic hypotension associated with nitric oxide production | Robert G. Kilbourn, Owen W. Griffith | 1996-07-09 |
| 5502050 | Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis | — | 1996-03-26 |
| 5395612 | Method for treating systemic hypotension caused by sepsis or cytokine using arginase in combination with an .alpha..sub.1 adrenergic agonist | Owen W. Griffith, Roberto Levi | 1995-03-07 |
| 5374651 | Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives | Robert G. Kilbourn, Owen W. Griffith | 1994-12-20 |
| 5334380 | Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension | Robert G. Kilbourn, Owen W. Griffith | 1994-08-02 |
| 5312835 | Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension | Robert G. Kilbourn, Owen W. Griffith | 1994-05-17 |
| 5286739 | Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor | Robert G. Kilbourn, Owen W. Griffith | 1994-02-15 |
| 5216025 | Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients | Robert G. Kilbourn, Roberto Levi | 1993-06-01 |
| 5028627 | Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor | Robert G. Kilbourn, Roberto Levi, Owen W. Griffith | 1991-07-02 |